Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 17,948	$ 5,091
Investments	48,823	108,095
Accounts receivable, net	9,319	7,022
Inventory	22,892	29,761
Prepaid expenses and other current assets	6,019	7,329
Restricted investments	35,117	0
Total current assets	140,118	157,298
Restricted cash	400	400
Property and equipment, net	23,345	18,029
Operating lease right-of-use assets	5,633	7,222
Finance lease right-of-use assets	3,503	3,707
Intangible assets, net	33,974	41,143
Goodwill	0	77,289
Other long-term assets	7,431	2,414
Total assets	214,404	307,502
Current liabilities:
Accounts payable	10,384	12,534
Accrued expenses	8,089	10,552
Contract liabilities	783	871
Operating lease liability	2,163	2,260
Finance lease liability	272	285
Contingent consideration	0	9,382
Purchase option liability (at fair value)	8,534	0
Convertible notes payable (at fair value)	69,803	0
Total current liabilities	100,028	35,884
Operating lease liability, net of current portion	3,590	5,504
Finance lease liability, net of current portion	3,585	3,619
Contingent consideration, net of current portion	10,890	12,970
Long-term contract liabilities	154	127
Total liabilities	118,247	58,104
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of December 31, 2023 and 2022	0	0
Common stock, $0.0001 par value, 400,000,000 shares authorized at December 31, 2023 and 2022; 45,752,000 and 29,718,000 shares issued and outstanding at December 31, 2023 and 2022, respectively	5	3
Additional paid-in capital	677,337	599,234
Accumulated deficit	(581,208)	(348,715)
Accumulated other comprehensive income (loss)	23	(1,124)
Total stockholders’ equity	96,157	249,398
Total liabilities and stockholders’ equity	$ 214,404	$ 307,502